Onconetix Inc (NASDAQ: ONCO) Is Rated A Buy By Analysts.

In the latest trading session, 0.89 million Onconetix Inc (NASDAQ:ONCO) shares changed hands as the company’s beta touched 3.14. With the company’s most recent per share price at $0.69 changing hands around $0.04 or 6.14% at last look, the market valuation stands at $5.72M. ONCO’s current price is a discount, trading about -3001.45% off its 52-week high of $21.40. The share price had its 52-week low at $0.32, which suggests the last value was 53.62% up since then. When we look at Onconetix Inc’s average trading volume, we note the 10-day average is 33.63 million shares, with the 3-month average coming to 5.63 million.

Onconetix Inc (NASDAQ:ONCO) trade information

Instantly ONCO is in green as seen in intraday trades today. With action -1.63%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 9.51%, with the 5-day performance at -1.63% in the red. However, in the 30-day time frame, Onconetix Inc (NASDAQ:ONCO) is 12.93% up. Looking at the short shares, we see there were 33333.0 shares sold at short interest cover period of 0.45 days.

Onconetix Inc (NASDAQ:ONCO)’s Major holders

Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 4.04 shares estimated at $2624.0 under it, the former controlled 0.05% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.02% of the shares, roughly 1.84 shares worth around $1194.0.